CPHI Worldwide - Networking arena for Pharma Professionals

CPHI Worldwide 2019 - Networking arena for Pharma Professionals

Read More
Remdesivir synthesis and its impurities

Remdesivir is a broad-spectrum antiviral drug developed by the Gilead Sciences1. It was originally developed to treat hepatitis C and was then tested against Ebola virus and Marburg virus, but was ineffective as per studies.

Read More
Enquire Now